Facebook reportedly shelved a report for the first quarter of 2021 that might have reflected poorly on the social networking giant for its handling of Covid misinformation on its platform.
The New York Times, which obtained a copy of the report, said that the most-viewed link in the first quarter had a headline that could promote Covid-19 vaccine hesitancy.
Fearing public outcry, Facebook suppressed the report.
One of the headlines in a Facebook post read, "A 'healthy' doctor died two weeks after getting a COVID-19 vaccine; CDC is investigating why."
The article was published by The South Florida Sun Sentinel and republished by The Chicago Tribune.
Facebook executives apparently "debated whether it would cause a public relations problem, according to the internal emails" and ultimately decided not to publish it, the NYT report mentioned on Friday.
"We considered making the report public earlier but since we knew the attention it would garner, exactly as we saw this week, there were fixes to the system we wanted to make," Facebook spokesman Andy Stone said in a statement.
Facebook this week released its first report on the most widely viewed content in News Feed, starting with domains, links, Pages and posts in the US.
Facebook said that to paint a complete picture and provide more extensive detail of what people actually see on its platform, it will release 'Widely Viewed Content Reports' on a quarterly basis, starting in the US and eventually including more international data.
--IANS
na/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)